Skip to main content
Equibles
OMDA logo

OMDA · Omada Health, Inc.

Track OMDA — free

Use OMDA with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$22.77 +0.48 (+2.15%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Market Cap
$1.39B
Shares
61.22M

OMDA metrics

67 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$22.77
Market cap
$1.39B

Price action

19 metrics
Price change (1W)
-3.9%
Price change (30D)
-8.9%
Price change (3M)
+27.0%
Price change (6M)
+62.1%
Price change (YTD)
+44.3%
Price change (1Y)
-4.0%
Trailing year
Price change (5Y)
—
52-week high
$26.78
52-week low
$10.94
Change from 52-week high
-15.0%
Change from 52-week low
+108.1%
Annualized volatility
59.5%
Beta
1.2
RSI (14D)
48.4
Price vs SMA 50
+0.5%
Price vs SMA 200
+34.1%
Avg volume (3M)
1.27M
Relative volume
0.7
Average dollar volume
$27.77M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
61.22M

Valuation

12 metrics
P / E (TTM)
21.3
Trailing earnings · reciprocal yield 4.7%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
4.5×
reciprocal yield 22.2%
P / book
5.5
reciprocal yield 18.1%
FCF yield
1.6%
TTM · current market cap
Buyback yield
—
P / FCF
61.3
reciprocal yield 1.6%
P / operating cash flow
58.9
reciprocal yield 1.7%
Earnings yield
0.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
68.2%
Operating margin
-0.1%
Trailing 12 months
Net margin
1.4%
Gross profit (TTM)
$211.21M
Operating profit (TTM)
−$464,000
Net income (TTM)
$4.30M
Trailing 12 months
Diluted EPS (TTM)
$1.07
FCF margin
7.3%
Effective tax rate
0.0%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-47.13

Growth

11 metrics
Revenue growth YoY
+43.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$309.76M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+191.1%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
1.7%
Return on assets
1.3%
Debt / equity
—
Current ratio
3.9
EBITDA (TTM)
$5.43M
Free cash flow (TTM)
$22.73M
Quick ratio
3.9
Interest coverage
-1.2
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$221.71M
Total assets
$328.22M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$23.68M
Capital expenditures (TTM)
$960,000
R&D (TTM)
$49.17M
SG&A (TTM)
—
Stock compensation (TTM)
$17.12M
R&D / revenue
15.9%
Stock compensation / revenue
5.5%

Ownership (13F)

3 metrics
13F filers
154
13F filer change QoQ
+14
Institutional ownership
89.6%

Short interest

3 metrics
Short interest
9.6%
Latest settlement · 3.1 days to cover
Days to cover
3.1d
Short-squeeze score
71 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$6.37M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1611115 CUSIP 68170A108 13F (30d) 109 filings 109 filers Visit website Investor relations